Return On Equity
62%
Trailing 12 months · Through 31 Mar 2024
YoY relative change: +1022%
Period Q1 2024 · Filed 14 May 2024
Return On Equity
62%
Trailing 12 months · Through 31 Mar 2024
YoY relative change: +1022%
Return On Assets
33%
Trailing 12 months · Through 31 Mar 2024
YoY relative change: +1273%
Operating Margin
13%
Trailing 12 months · Through 31 Mar 2024
YoY relative change: +299%
Current Ratio
1.71x
Period-end balance · Through 31 Mar 2024
YoY relative change: -43%
Quick Ratio
0.81x
Period-end balance · Through 31 Mar 2024
YoY relative change: -48%
Debt-to-equity
0.86x
Period-end balance · Through 31 Mar 2024
YoY relative change: -39%
Revenues YoY
18%
Trailing 12 months · Through 31 Mar 2024
NetIncomeLoss YoY
1654%
Trailing 12 months · Through 31 Mar 2024
| Metric | Latest value | YoY relative change |
|---|---|---|
| Return On Equity |
62%
Trailing 12 months · 31 Mar 2024
|
+1022% |
| Return On Assets |
33%
Trailing 12 months · 31 Mar 2024
|
+1273% |
| Operating Margin |
13%
Trailing 12 months · 31 Mar 2024
|
+299% |
| Metric | Latest value | YoY relative change |
|---|---|---|
| Current Ratio |
1.71x
Period-end balance · 31 Mar 2024
|
-43% |
| Quick Ratio |
0.81x
Period-end balance · 31 Mar 2024
|
-48% |
| Debt-to-equity |
0.86x
Period-end balance · 31 Mar 2024
|
-39% |
| Metric | Latest value | YoY relative change |
|---|---|---|
| Revenues YoY |
18%
Trailing 12 months · 31 Mar 2024
|
|
| NetIncomeLoss YoY |
1654%
Trailing 12 months · 31 Mar 2024
|
| Metric | Latest value | YoY relative change |
|---|---|---|
| Entity Common Stock, Shares Outstanding |
14,250,975
Period-end balance · 28 Mar 2024
|
+0.35% |
| Common Stock, Value, Issued |
$142,557
Period-end balance · 31 Mar 2024
|
+0.35% |
| Weighted Average Number of Shares Outstanding, Basic |
14,250,975
Reported period · 31 Mar 2024
|
+1.2% |
| Weighted Average Number of Shares Outstanding, Diluted |
17,189,908
Reported period · 31 Mar 2024
|
+16% |
These supporting metrics stay fully source-backed for deeper research. Scan the latest value and reported period first, then open a metric page when you need the full filing trail.
| Metric | Latest value | YoY relative change |
|---|---|---|
| Accounts Receivable, after Allowance for Credit Loss, Current |
$1,333,777
Period-end balance · 31 Mar 2024
|
-9.2% |
| Assets |
$12,543,820
Period-end balance · 31 Mar 2024
|
+36% |
| Assets, Current |
$8,041,584
Period-end balance · 31 Mar 2024
|
+21% |
| Cash and Cash Equivalents, at Carrying Value |
$2,496,476
Period-end balance · 31 Mar 2024
|
+25% |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$2,496,476
Period-end balance · 31 Mar 2024
|
+25% |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$476,908
Reported period · 31 Mar 2024
|
-5412% |
| Common Stock, Par or Stated Value Per Share |
0.01
Period-end balance · 31 Mar 2024
|
0% |
| Common Stock, Shares Authorized |
60,000,000
Period-end balance · 31 Mar 2024
|
0% |
| Common Stock, Shares, Issued |
14,255,575
Period-end balance · 31 Mar 2024
|
+0.35% |
| Contract with Customer, Liability, Current |
$1,057,053
Period-end balance · 31 Mar 2024
|
-2% |
| Costs and Expenses |
$11,266,686
Trailing 12 months · 31 Mar 2024
|
+5.9% |
| Deferred Income Tax Assets, Net |
$1,970,000
Period-end balance · 31 Mar 2024
|
|
| Depreciation, Depletion and Amortization |
$88,635
Reported period · 31 Mar 2024
|
+19% |
| Earnings Per Share, Basic |
0
Trailing 12 months · 31 Mar 2024
|
+1150% |
| Earnings Per Share, Diluted |
0
Trailing 12 months · 31 Mar 2024
|
+950% |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest |
$1,585,011
Trailing 12 months · 31 Mar 2024
|
+682% |
| Increase (Decrease) in Accounts Receivable |
$258,219
Reported period · 31 Mar 2024
|
-429% |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
$41,500
Reported period · 31 Mar 2024
|
-2.2% |
| Inventory, Net |
$3,380,662
Period-end balance · 31 Mar 2024
|
+13% |
| Liabilities |
$4,983,941
Period-end balance · 31 Mar 2024
|
-7% |
| Liabilities and Equity |
$12,543,820
Period-end balance · 31 Mar 2024
|
+36% |
| Liabilities, Current |
$4,702,959
Period-end balance · 31 Mar 2024
|
+115% |
| Net Cash Provided by (Used in) Financing Activities |
$12,074
Reported period · 31 Mar 2024
|
-179% |
| Net Cash Provided by (Used in) Investing Activities |
$368,484
Reported period · 31 Mar 2024
|
-96% |
| Net Cash Provided by (Used in) Operating Activities |
$96,350
Reported period · 31 Mar 2024
|
-159% |
| Nonoperating Income (Expense) |
$140,597
Trailing 12 months · 31 Mar 2024
|
+14% |
| Operating Income (Loss) |
$1,725,610
Trailing 12 months · 31 Mar 2024
|
+372% |
| Operating Lease, Liability, Current |
$313,567
Period-end balance · 31 Mar 2024
|
+5.2% |
| Operating Lease, Liability, Noncurrent |
$54,027
Period-end balance · 31 Mar 2024
|
-85% |
| Operating Lease, Payments |
$200,000
Reported period · 31 Mar 2024
|
0% |
| Operating Lease, Right-of-Use Asset |
$367,593
Period-end balance · 31 Mar 2024
|
-45% |
| Other Assets, Current |
$830,669
Period-end balance · 31 Mar 2024
|
+422% |
| Other Assets, Noncurrent |
$26,993
Period-end balance · 31 Mar 2024
|
0% |
| Payments to Acquire Property, Plant, and Equipment |
$368,484
Reported period · 31 Mar 2024
|
+96% |
| Property, Plant and Equipment, Gross |
$16,699,043
Period-end balance · 31 Mar 2024
|
+3.4% |
| Property, Plant and Equipment, Net |
$1,575,741
Period-end balance · 31 Mar 2024
|
+16% |
| Retained Earnings (Accumulated Deficit) |
$12,736,942
Period-end balance · 31 Mar 2024
|
+22% |
| Share-based Payment Arrangement, Noncash Expense |
$28,292
Reported period · 31 Mar 2024
|
-17% |
| Stockholders' Equity Attributable to Parent |
$7,559,879
Period-end balance · 31 Mar 2024
|
+95% |
Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Open metric pages to inspect the reported history.
Company facts change as new 10-Q and 10-K filings update the latest reported period, headline values, and cross-company comparison context.
Freshness comes from the latest SEC company facts period available for this filer and the linked metric history pages.
Latest update
Latest financial period: Q1 2024. Reopen this facts page to verify the newest reported period against the prior baseline.
Update date
14 May 2024
Page type
Company facts
Latest period
Q1 2024
SEC-backed company facts were refreshed from filings filed on 14 May 2024.
Benchmark Context
Return On Equity is up about 1022% versus the comparable prior period.
Compared with
Compared with Inrad Optics, Inc.'s recent history first. Same-industry peer context appears only when enough SEC-backed benchmark coverage exists.
Why this is notable
Return On Equity already has a self-history signal here, but same-industry benchmark context waits until the benchmark sample is strong enough.
Industry benchmark context uses SEC-reported values from the same methodology version. Latest periods may differ across companies.
These short guides explain what the headline metrics mean, what to compare next, and where to open the live SEC-backed example for this company.
Plain-English Guide
Revenue is the sales a company reports from customers before most expenses are subtracted.
Why people care
People start here to understand business scale and whether demand is growing before they ask about margins or cash flow.
How to read it
Check the latest reported period first, then compare the same quarter or year against prior periods so seasonality does not distort the story.
Compare next
Compare revenue with gross profit, operating income, and operating cash flow to see whether sales are turning into healthy economics.
Revenue can jump because of acquisitions, pricing changes, or revenue-recognition rules, and reporting periods may differ across companies.
Open a live SEC-backed example
Plain-English Guide
Net income is profit after operating costs, interest, taxes, and other non-operating items.
Why people care
It is the bottom-line profit figure many users recognize first, especially when they want to compare earnings with sales or cash flow.
How to read it
Use the same quarter or fiscal year comparison first, then check operating income or cash flow if the bottom line moved sharply.
Compare next
Compare it with operating income, EPS, and operating cash flow to see whether earnings are broad-based or driven by one-off items.
Net income can swing because of tax, financing, or accounting adjustments, so it is often less comparable than core operating metrics.
Open a live SEC-backed example
Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Open company facts to inspect the reported metric history.
Latest financial snapshot (2024-03-31) highlights Return On Equity 62.2%, Return On Assets 32.6%, and Operating Margin 13.3%.
SEC-only DCF estimate using a normalized free cash flow base, cash, debt, and reported share count when available.
Fair value per share
$0.6744
Market price
n/a
PEG ratio
n/a
Enterprise value
$9.1M
Equity value
$11.59M
Bear
$0.5402
Base
$0.6744
Bull
$0.8858
Base growth: DCF Growth Assumption.
EV/Revenue
n/a
Market price market EV / SEC revenue
Market enterprise value is unavailable
EV/EBITDA
n/a
Market price market EV / SEC EBITDA
Market enterprise value is unavailable
P/E
n/a
Market price market price / SEC EPS
Market cap is unavailable
P/S
n/a
Market price market cap / SEC revenue
Market cap is unavailable
P/B
n/a
Market price market cap / SEC equity
Market cap is unavailable
PEG
n/a
P/E / EPS CAGR
P/e or positive growth is unavailable
Use these links to compare Inrad Optics, Inc. against other SEC filers on the same metric, then verify the company history from the paired facts page.
Latest value: 18%
Latest value: 1654%
Transparent 0-100 scoring model based on profitability, financial health, and growth factors.
91.4/100
Strong Confidence high
62%
Metric score 100.0/100
33%
Metric score 100.0/100
Return On Equity, Return On Assets, and Current Ratio
No major risk flags from available metrics.
This score is transparent and deterministic. We weight profitability, financial health, and growth metrics, then renormalize weights when SEC data is missing.
| Metric | Weight | V1 threshold |
|---|---|---|
| ROIC | 20 | 5% to 20% |
| ROE | 15 | 8% to 25% |
| ROA | 10 | 2% to 10% |
| Operating Margin | 5 | 5% to 25% |
| Current Ratio | 12 | 1.0x to 2.0x |
| Quick Ratio | 8 | 0.8x to 1.5x |
| Debt to Equity | 10 | 0.3x to 2.0x (lower is better) |
| Revenue YoY | 10 | -10% to +20% |
| Net Income YoY | 10 | -10% to +20% |
Metrics are computed with a market-consensus convention designed for cross-portal comparability.
CIK / security context first